looking forward to some clarity on the quarterly c

looking forward to some clarity on the quarterly call.

such a bizarre, long-term experience, at least for me. on the one-hand, it's really exciting to hear about these great things our drug can do. on the other, it's incredibly frustrating that none of them are able to get any traction - nor have they been able to for years. and as we read in the news, research / new treatments are advancing rapidly - and i can only assume AI will further accelerate the discovery of new compounds. it's like having a tricked out ski boat, but the engine isn't working. you're sitting in the middle of the lake stalled out, while lesser boats cruise by. technical specs of low wind drag, turning radius, etc. of your boat can only give so much consolation as you sit in the middle of the lake.

personally, i am hoping for some solution that's very different from the long-term build out here. whether it's Cyrus or someone else, can we get creative about monetizing this compound? personally, i'd take less money now, than multiple more years here for more money. i've just got other things i need to do, and my money has been tied up way too long now. i know some disagree - and that's fine. if i were just buying in at .25 and brand new as an investor, i'd be gung ho for a 5-10 year run also.

hoping (praying?) that this next call provides some clarity about how we can finally get something going here.